An open letter signed by more than 50 industry executives blasts a “fundamentally, fatally flawed” report that urges greater ...

A group of 53 biotech leaders are expressing their support for mifepristone in a letter to the Food and Drug Administration, ...

HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone​," but experts say concerns ...

CHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and ...

A North Texas man charged with capital murder after slipping mifepristone into his girlfriend’s food signals another attempt ...

In patients with hypercortisolism and inadequately controlled type 2 diabetes, mifepristone lowered HbA1c levels by about 1.5 ...

Researchers have discovered in a randomized placebo-controlled trial that mifepristone (Korlym) led to a significant ...

Every week, The Post runs a collection of letters of readers’ grievances — pointing out grammatical mistakes, missing coverage and inconsistencies. These letters tell us what we did wrong and, ...

CHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and hypercortisolism, a randomized placebo-controlled trial showed. Among 136 ...

CHICAGO — Mifepristone treatment improved glycemic control and led to weight loss and a reduction of waist circumference in patients with poorly controlled type 2 diabetes (T2D) and hypercortisolism, ...